Results 81 to 90 of about 687,796 (199)

HIV-Associated Progressive Multifocal Leukoencephalopathy: A Case Study

open access: yesActa Medica Indonesiana, 2023
Progressive multifocal leukoencephalopathy (PML) is a rare, life-threatening, infectious, lytic, demyelinating disease that results from reactivation of the virulent JC polyomavirus (JCV) “major opportunistic infection” in immunosuppressed individuals ...
Elsayed Abed   +10 more
doaj   +2 more sources

A case of developing progressive multifocal leukoencephalopathy while using rituximab and mycophenolate mofetil in refractory systemic lupus erythematosus

open access: yes, 2018
Yuichi Ishikawa, Tadamichi Kasuya, Junichi Ishikawa, Michio Fujiwara, Yasuhiko Kita Department of Rheumatology, Yokohama Rosai Hospital, Kohoku-ku, Yokohama, Kanagawa, Japan Abstract: Progressive multifocal leukoencephalopathy (PML) is a central ...
Fujiwara M   +4 more
core  

What is the risk of progressive multifocal leukoencephalopathy in patients with ulcerative colitis or Crohn’s Disease treated with vedolizumab? [PDF]

open access: yes, 2018
Background: Progressive multifocal leukoencephalopathy is a serious condition linked to certain diseases and immunosuppressant therapies, including the α4 integrin antagonist natalizumab.
Card, Timothy R.   +7 more
core   +1 more source

Progressive Multifocal Leukoencephalopathy in a Kidney Transplant Recipient

open access: yesTurkish Journal of Nephrology
Cite this article as: Tahillioglu Y, Mirioglu S, Ucar AR, et al. Progressive multifocal leukoencephalopathy in a kidney transplant recipient. Turk J Nephrol. 2026;35(3):256-257.
Yağmur Tahıllıoğlu   +6 more
doaj   +1 more source

A Representative Survey of M.S. Patients on Attitudes toward the Benefits and Risks of Drug Therapy [PDF]

open access: yes
Background: Although M.S. patients face significant trade-offs between risks and benefits of drug therapy, little is known of their attitudes toward these risks and benefits.
Calfee, John E.
core  

Progressive multifocal leukoencephalopathy - the importance of early diagnosis illustrated in four cases.

open access: yes, 2008
Progressive multifocal leukoencephalopathy (PML) is a rare, deadly demyelinating disease of the central nervous system, which is caused by a reactivation of the DNA polyomavirus JC and occurs in immunosuppressed individuals.
Nived, Ola   +3 more
core   +1 more source

Immunology of progressive multifocal leukoencephalopathy [PDF]

open access: yes, 2021
The high prevalence of asymptomatic JC polyomavirus (JCV) infection in the general population indicates coexistence with the human host and efficient immune control in healthy individuals.
Jelcic, Ilijas   +4 more
core  

Progressive multifocal leukoencephalopathy in HIV with atypical presentation and prognostic outcome causing diagnostic dilemma: a case report [PDF]

open access: yes
Progressive multifocal leukoencephalopathy (PML) is a rare demyelinating disease caused by John Cunningham virus (JCV) that affects immunocompromised individuals, particularly human immunodeficiency virus (HIV)-positive.
Wan Ahmad Kammal, Wan Syahira Ellani   +11 more
core   +1 more source

Visual consequences of medications for multiple sclerosis: the good, the bad, the ugly, and the unknown

open access: yesEye and Brain, 2017
Heather E Moss1,2 1Department of Ophthalmology, Stanford University, Palo Alto, CA, USA; 2Department of Neurology & Neuroscience, Stanford University, Stanford, CA, USA Abstract: Multiple sclerosis (MS) is associated with vision changes both due to ...
Moss HE
doaj  

Home - About - Disclaimer - Privacy